Outpatient Care Stocks Jump 35% as DaVita Leads Q1 Beats, Raises 2026 Outlook

Outpatient and specialty care stocks reported a strong first quarter, with revenues across seven tracked companies surpassing analyst estimates by 1.9%, sending the group’s shares up an average 35% since reporting, as of June 5, 2026. DaVita (NYSE:DVA) drove the rally, posting a 6% year-over-year revenue increase to $3.42 billion, beating consensus by 2.1%, and raising its full-year earnings guidance. The stock has climbed 22.4% to $192.24. agilon health (NYSE:AGL) soared 236% after a guidance hike and an earnings beat, despite losing 85,000 patients to end the quarter with 426,000. U.S. Physical Therapy (NYSE:USPH) fell 16.1% after missing earnings estimates by a wide margin, the weakest result in the group. Surgery Partners (NASDAQ:SGRY) slipped 2.5% even after topping revenue and earnings forecasts, as its full-year outlook disappointed. LifeStance Health (NASDAQ:LFST) surged 21.2% in revenue and rose 4.6%. Tailwinds from an aging population and a shift to value-based care support the sector, though Medicare reimbursement risks persist.